The company aims for its medical devices business to account for about 25% of its revenues over the next three years. Some of its prominent clientele in this segment include Sanofi, Zydus ...

Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control in ...